Hydrops fetalis is a serious condition in which abnormal fluid accumulates in at least two body compartments of a developing fetus, such as the chest cavity, abdomen, the sac around the heart, or beneath the skin.1The Obstetrician & Gynaecologist. Non‐immune hydrops fetalis: a practical guide for obstetricians Causes range from blood-type incompatibility between mother and fetus to chromosomal disorders, heart rhythm problems, infections, and inherited metabolic diseases. Early recognition on ultrasound has transformed how the condition is managed, and a growing number of fetal therapies can now be delivered before birth.
Why Fluid Accumulates
At its core, hydrops reflects a breakdown in the balance between fluid entering fetal tissues and fluid draining back into the bloodstream. Under normal circumstances, a small amount of fluid filters out of tiny blood vessels into surrounding tissue and is returned via the lymphatic system. When something disrupts that cycle, fluid pools faster than it can be cleared.2PubMed. Non-immune hydrops fetalis: a short review of etiology and pathophysiology The disruption can come from several directions: the heart may not pump strongly enough, venous pressure may climb too high, the blood may carry too few red cells to maintain normal circulation, or the lymphatic channels themselves may be malformed or overwhelmed.
Cardiac dysfunction is a common thread across many otherwise different causes. When the fetal heart struggles, whether from a structural defect, an abnormal rhythm, or severe anemia, central venous pressure rises. Studies have shown a direct linear relationship between rising venous pressure and an enlarged heart, and those fetuses with the highest pressures also had the most pronounced abdominal fluid collections.3PubMed. Umbilical venous pressure in nonimmune hydrops fetalis: correlation with cardiac size In practical terms, the fetal heart is trying to compensate for whatever the underlying problem is, and when compensation fails, the fluid buildup follows.
Immune Versus Non-Immune Hydrops
Historically, the most common trigger was Rh incompatibility. If a mother with Rh-negative blood carried an Rh-positive fetus, her immune system could produce antibodies that crossed the placenta and destroyed the baby’s red blood cells.4PubMed. Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management The resulting severe anemia stressed the fetal heart and liver, eventually leading to fluid accumulation. In the most severe form, the fetal immune system’s ability to compensate collapses: red blood cells are destroyed not just by tissue-based immune cells but also directly within the bloodstream, which worsens anemia sharply.5PubMed. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns
The widespread use of anti-D immune globulin (commonly known as RhoGAM) has made Rh-related hydrops quite rare in countries with access to routine prenatal care. But Rh is not the only blood-group antigen that can trigger antibodies. The Kell antigen, for instance, is the most potent immunogenic antigen after Rh D. Kell-related antibody disease appears in a small fraction of pregnancies, yet it accounts for roughly one in ten cases of severe fetal anemia caused by blood-group antibodies.6PubMed Central. Approach to Pregnancy Affected by Kell Alloimmunization Kell antibodies are especially tricky because they suppress new red blood cell production in the fetal bone marrow rather than simply destroying circulating cells, which means standard markers of red cell breakdown can underestimate how anemic the fetus actually is.
With immune-mediated cases declining, non-immune hydrops fetalis now accounts for the large majority of cases seen in practice. Its causes are remarkably diverse, spanning genetic abnormalities, heart defects, infections, thoracic masses, and metabolic disorders, among others.
Chromosomal and Genetic Causes
Chromosomal abnormalities are among the most frequent identifiable causes, especially when hydrops appears early in pregnancy. In one referral-center cohort of 129 cases of non-immune hydrops, chromosomal problems were found in about 30% overall. The proportion was strongly linked to gestational age: roughly two-thirds of first-trimester cases had a chromosomal abnormality, compared with about 30% in the second trimester and only around 8% in the third. The most common were trisomy 21 (Down syndrome), monosomy X (Turner syndrome), and trisomy 18.7PubMed Central. Genetic disorders and pregnancy outcomes of non-immune hydrops fetalis in a tertiary referral center
Beyond whole-chromosome problems, a growing number of single-gene disorders are recognized as causes. A large systematic review identified 131 genes with strong evidence for a link to non-immune hydrops, with dozens more showing emerging or limited evidence. The largest category was inborn errors of metabolism, making up about 28% of genetic causes with strong or emerging evidence, followed by syndromic conditions, neuromuscular disorders, blood diseases, and skeletal abnormalities.8Genetics in Medicine. A systematic review of monogenic etiologies of nonimmune hydrops fetalis That breadth helps explain why reaching a specific diagnosis can be so difficult: the list of possible single-gene causes is genuinely enormous.
Infections, Thoracic Masses, and Twin Complications
Among infectious causes, parvovirus B19 (the virus behind “fifth disease” in children) stands out. It targets red blood cell precursors in the fetal bone marrow, halting production and causing severe anemia. Parvovirus is considered a leading infectious cause of non-immune hydrops, and outbreaks directly correlate with spikes in fetal anemia and hydrops cases.9PubMed Central. Neonatal management of parvovirus B19-induced hydrops fetalis: a case report Other infections, including cytomegalovirus and syphilis, also contribute but are less common triggers.
Space-occupying lesions in the fetal chest are another category. Congenital lung malformations or large pleural effusions can compress the heart and great vessels, raising venous pressure and reducing the heart’s ability to fill and pump. Research on congenital pulmonary airway malformations has shown that increasing displacement of the heart and mediastinum correlates with the development of hydrops, consistent with a compression-driven mechanism.10PubMed Central. Fetal Congenital Pulmonary Airway Malformation: The Role of an Objective Measurement of Cardiomediastinal Shift
In monochorionic twin pregnancies (identical twins sharing one placenta), twin-to-twin transfusion syndrome is a recognized cause. Shared blood vessel connections in the placenta allow one twin to receive too much blood flow while the other is deprived. In rare and dramatic scenarios, if the recipient twin dies, the surviving donor twin can develop hydrops rapidly, possibly from a sudden shift of blood across the shared connections into the now-low-resistance circulation of the deceased twin.11PubMed. Rapid development of hydrops fetalis in the donor twin following death of the recipient twin in twin-twin transfusion syndrome
Lysosomal Storage Disorders as a Hidden Cause
Lysosomal storage disorders deserve a separate mention because they are probably underdiagnosed. These are inherited conditions in which the cell’s waste-disposal system does not work properly, causing toxic material to build up inside cells. Their link to hydrops is not intuitive, but the swelling appears to result from damage to blood vessels, the lymphatic system, or the liver and bone marrow.
Estimates of how often these disorders cause non-immune hydrops have shifted upward over time. An older analysis placed the incidence at about 5% of all tested cases, and closer to 17% when only the “unexplained” cases were counted.12PubMed. Lysosomal storage disease as an etiology of nonimmune hydrops A more recent and larger systematic review using updated testing methods found lysosomal storage disorders in roughly 7% of all tested non-immune hydrops cases and about 8% of those previously labeled idiopathic.13PubMed Central. Lysosomal storage disorders as an etiology of nonimmune hydrops fetalis: A systematic review The most commonly identified conditions were mucopolysaccharidosis type VII, galactosialidosis, Gaucher disease, and GM1 gangliosidosis. Because hydrops caused by these disorders can sometimes resolve on its own before birth, cases that transiently improve and are never tested may slip through unrecognized.14PubMed Central. Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature
How Hydrops Is Diagnosed
Ultrasound is the primary tool. The hallmark finding is abnormal fluid in two or more separate compartments: fluid around the lungs (pleural effusion), fluid in the abdomen (ascites), fluid around the heart (pericardial effusion), or generalized skin thickening (subcutaneous edema).1The Obstetrician & Gynaecologist. Non‐immune hydrops fetalis: a practical guide for obstetricians A thickened, swollen placenta (placentomegaly) often accompanies these findings. Ultrasound also assesses the heart for structural defects, abnormal rhythms, and signs of heart failure such as poor contractility and an enlarged heart.15PubMed Central. Prenatal Diagnosis of Fetal Heart Failure
When antibody-mediated anemia is suspected, Doppler measurement of blood flow speed in the fetal middle cerebral artery has become the standard non-invasive screening method. An anemic fetus has thinner blood that flows faster through the brain. A landmark study showed that peak flow velocity in this artery detected moderate or severe anemia with 100% sensitivity, whether or not hydrops was already present, with a false positive rate of just 12%.16PubMed. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization This technique largely replaced the older approach of sampling amniotic fluid to estimate the severity of red blood cell breakdown, which required an invasive needle procedure.
The Growing Role of Genetic Testing
When chromosomal analysis and standard workup fail to identify a cause, exome sequencing (reading the protein-coding portions of the fetal genome) is increasingly used. A systematic review and meta-analysis of 31 studies found that prenatal exome sequencing identified a genetic diagnosis in about 37% of non-immune hydrops cases that had already tested normal on standard chromosomal analysis.17PubMed. Diagnostic yield from prenatal exome sequencing for non-immune hydrops fetalis: A systematic review and meta-analysis In one focused study of 22 fetal exomes, half received a definitive diagnosis, with the findings spanning Noonan syndrome variants, muscle disorders, metabolic conditions, and a congenital anemia.18Genetics in Medicine. High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study
These results matter beyond the current pregnancy. A specific genetic diagnosis tells parents whether the condition is likely to recur in future pregnancies and may open the door to targeted treatments, either in the current fetus or after birth. Without a diagnosis, families are left guessing at recurrence risk, which can be deeply distressing.
Fetal Treatment for Anemia
Intrauterine blood transfusion is the best-established fetal therapy for hydrops caused by anemia, whether from Rh disease, Kell antibodies, or parvovirus infection. Under ultrasound guidance, a needle is inserted into the umbilical vein, a small blood sample is drawn to confirm fetal blood type and measure the starting blood count, and then carefully prepared packed red blood cells are slowly infused. The donor blood is O-negative, irradiated, and processed to remove white blood cells and preservative solution.19PubMed Central. Intrauterine transfusion in hydropic fetuses: An outcome analysis
The procedure is effective but not without risk, and hydropic fetuses are the most fragile recipients. One experienced center reported no fetal or neonatal deaths across 135 transfusions in 56 fetuses, with mild complications in about 10% and severe complications in roughly 1.5%. Hydrops and accessing a free-floating loop of umbilical cord (as opposed to the cord insertion site) were associated with higher complication rates.20PubMed Central. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven Fetuses with hydrops tend to present with lower starting blood counts and are more likely to need alternative transfusion approaches when the standard intravascular route proves technically difficult.21PubMed. Fetal Anemia: Determinants and Perinatal Outcomes according to the Method of Intrauterine Blood Transfusion
Treating Fetal Heart Rhythm Problems
Fetal supraventricular tachycardia, a rapid abnormal heart rhythm, is one of the more treatable causes of hydrops. The fast heart rate prevents the heart from filling properly, leading to heart failure and fluid buildup. Because the drugs cannot be given directly to the fetus in most cases, treatment is transplacental: the mother takes oral medication, which crosses the placenta and reaches the fetal heart.
Digoxin has been the traditional first-line drug, but evidence suggests it works less well in the presence of hydrops, possibly because the swollen placenta transfers the drug less efficiently. A systematic review and meta-analysis found that among hydropic fetuses, flecainide was significantly more likely to terminate the abnormal rhythm than digoxin.22PubMed Central. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis Current protocols often use a stepped approach: digoxin alone is tried first, and if conversion does not occur, flecainide or sotalol is added or substituted. A multicenter trial using this type of stepwise protocol achieved resolution of the abnormal rhythm in about 90% of cases overall, and in three of four hydropic cases.23PubMed. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial One published case of arrhythmia-induced hydrops treated with digoxin and flecainide together demonstrated that the combination could convert the rhythm and resolve ascites and pleural effusion within four days.24PubMed Central. Complete resolution of arrhythmia-induced hydrops fetalis in utero
Shunts for Thoracic Fluid Collections
When a large pleural effusion or cystic lung malformation is compressing the heart and causing hydrops, draining the fluid can relieve the pressure. This is done by placing a small plastic tube (a thoracoamniotic shunt) through the fetal chest wall under ultrasound guidance, creating a channel for fluid to drain continuously into the amniotic space. In a series of five fetuses with thoracic malformations and hydrops, all had successful decompression with lung re-expansion and resolution of hydrops, and all pregnancies reached at least 30 weeks.25PubMed Central. Percutaneous In Utero Thoracoamniotic Shunt Creation for Fetal Thoracic Abnormalities Leading to Non-Immune Hydrops
Larger studies of shunting for pleural effusions with secondary hydrops report survival rates of around 57% to 72%, with premature delivery being the primary source of complications among survivors.26PubMed. Thoracoamniotic shunting for fetal pleural effusions with hydrops 27PubMed. Long-Term Outcomes After Thoracoamniotic Shunt for Pleural Effusions With Secondary Hydrops Encouragingly, long-term data suggest that the majority of survivors do not carry major ongoing health problems. Shunt displacement is a known complication; sometimes the tube migrates and a second procedure is needed.
Prognosis and the Factors That Matter Most
Outcomes in hydrops fetalis vary enormously depending on the underlying cause, how early in pregnancy the condition appears, and whether an effective treatment exists. A large study of over 1,000 cases of non-immune hydrops from southern China illustrates the range: survival was highest when the cause was a gastrointestinal or urinary tract abnormality, and lowest when chromosomal or hematologic disease was responsible. Earlier gestational age at delivery and lower birthweight were the strongest risk factors for death. The analysis identified a birthweight cutoff of about 2,575 grams and a gestational age of roughly 37 weeks as thresholds below which outcomes worsened sharply.28Scientific Reports. Etiology and Outcome of non-immune Hydrops Fetalis in Southern China: report of 1004 cases
Fetal therapy does appear to improve survival. A study comparing outcomes with and without prenatal intervention reported mortality of about 29% overall, and earlier diagnosis was linked to worse outcomes, partly because first-trimester hydrops is more likely to have a chromosomal cause.29PubMed Central. Survival of Hydrops Fetalis with and without Fetal Intervention A separate analysis similarly found that fetal therapy was associated with significantly lower perinatal mortality, and that earlier gestational age at diagnosis correlated with higher risk of aneuploidy and worse outcomes.30PubMed. Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis These findings underscore that the “cause behind the cause” matters enormously: hydrops caused by a treatable arrhythmia has a fundamentally different trajectory than hydrops caused by a lethal chromosomal condition.
Mirror Syndrome and Risks to the Mother
Hydrops fetalis is not solely a fetal problem. A condition called mirror syndrome (also known as Ballantyne syndrome) can develop in the mother, in which her body begins to “mirror” the fetal edema. The hallmark features include rapid weight gain, generalized swelling, low blood protein levels, anemia, and new-onset high blood pressure. A systematic review found maternal edema in about 62% of mirror syndrome cases, low albumin in about 55%, anemia in 39%, and new-onset hypertension in 39%. In one case series, weight gain and low blood count were universal, and hypertension was present in 90%.31PubMed. Mirror syndrome: a systematic literature review 32PubMed Central. Clinical presentation and maternal-fetal outcomes of Mirror Syndrome: A case series of 10 affected pregnancies
Mirror syndrome can be easily confused with preeclampsia, and the distinction matters because the treatments differ. Major maternal complications are common, including postpartum hemorrhage, need for blood transfusion, and intensive care admission. When the underlying fetal condition is treated successfully (for example, by correcting fetal anemia with a transfusion), mirror syndrome often resolves. But when the fetal condition is not treatable, delivery may be the only way to protect the mother.
Delivery Room Challenges
Babies born with active hydrops present some of the most complex resuscitations in neonatal medicine. The fluid in their chest can prevent the lungs from expanding, and the abdominal swelling can push the diaphragm upward, further compromising breathing. Successful resuscitation requires an experienced, prepared team and rapid interventions that may include draining chest or abdominal fluid within the first minutes of life.33PubMed. The delivery room resuscitation of the hydropic neonate
An emerging approach involves beginning resuscitation while the baby is still connected to the placenta via an intact umbilical cord. In one reported case of a preterm infant with hydrops and bilateral chest fluid, the neonatal team drained the chest effusions while the cord was still pulsing, allowing the baby to receive oxygen via the placenta during a period when the lungs could not yet function. The newborn was stabilized before the cord was clamped and mechanical breathing support was initiated.34PubMed Central. Resuscitation with Intact Placental Circulation in a Preterm Infant with Hydrops Fetalis This strategy avoids a gap during which the baby has neither functioning lungs nor placental support, which can be hemodynamically dangerous.
When Treatment Is Not Possible
Not every case of hydrops fetalis has a treatable cause. When genetic testing reveals a lethal chromosomal disorder, or when the fetus has severe structural anomalies incompatible with life, families face profoundly difficult decisions. Perinatal palliative care has an essential role in these situations: it focuses on quality of life, respects the family’s values, and coordinates care across obstetric and neonatal teams. Palliative care does not mean abandoning medical support; it can be offered alongside life-prolonging measures and can shift toward comfort care if the clinical picture makes that appropriate. Early involvement of a specialized palliative care team is strongly recommended so that families have time and support to navigate goals of care rather than facing rushed decisions in a crisis.35Research and Reports in Neonatology. Hydrops fetalis: Incidence, Etiologies, Management Strategies, and Outcomes
Even when the prognosis is poor, reaching a specific genetic diagnosis carries value. Knowing the exact cause helps families understand what happened, informs genetic counseling for future pregnancies, and in some cases connects them with patient communities or research efforts. The expansion of prenatal genomic testing has made it possible to provide answers in situations that were previously filed as unexplained, which many families describe as offering at least some measure of closure.